Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Compellis, PBRI Conclude CP404 Obesity Therapy Phase I Study
CP404 is a calcium channel blocker used in oral dosage form to treat high-blood pressure. The novel mechanism for the drug therapy is based on the inhibition of
CP404 is a calcium channel blocker used in oral dosage form to treat high-blood pressure. The novel mechanism for the drug therapy is based on the inhibition of
Oracal trial is a multinational, randomised, double-blind, placebo-controlled Phase III trial designed to enroll about 550 patients. Tarsa Therapeutics also stated that the independent Data Monitoring Committee (DMC)
PharmCentre said that its presence along with other locations in US and Philippines offer 24×7 coverage of it’s services to customers. PharmCentre believes that call management plays a
NovaBay Pharma’s dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or
GSK stated that the post-marketing study is designed to examine the comparative cardiovascular safety of Rosiglitazone (Avandia) and Pioglitazone (Actos) in patients with type 2 diabetes which was
SiDMAP and Roche have presented the results of the study, entitled ‘A Novel Approach for the Treatment of Type 2 Diabetes (T2D): Characterisation of a Potent, Orally Active,
Somaxon Pharma claimed that Silenor binds with high affinity to histamine (H1) receptors. This is believed to be the mechanism by which Silenor promotes the maintenance of sleep.
Bupropion HCl SR tablets, used in the treatment of major depressive disorder, are the generic equivalent of GlaxoSmithKline’s Wellbutrin SR and are now available from Actavis in the
NicOx was informed by the FDA that the review of the NDA is complete and that it does not approve the Naproxcinod application. FDA has recommended NicOx to
Based on the growth of the clinical research market and the demand for outsourced eClinical services, unithink claimed that it has increased its operations by 50% in the